These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6393476)

  • 1. [Pathophysiological classification of Raynaud's syndrome].
    Kristensen JK; Nielsen HV
    Ugeskr Laeger; 1984 May; 146(22):1619-21. PubMed ID: 6393476
    [No Abstract]   [Full Text] [Related]  

  • 2. Diltiazem and Raynaud's syndrome.
    Matoba T; Ogata M; Kuwahara H
    Ann Intern Med; 1982 Sep; 97(3):455. PubMed ID: 7051914
    [No Abstract]   [Full Text] [Related]  

  • 3. [The natural course of Raynaud's phenomenon].
    Clavijo F; Krahenbuhl B
    Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon. Classification and definitions.
    Wouda AA
    Vasa Suppl; 1987; 18():4-9. PubMed ID: 3474799
    [No Abstract]   [Full Text] [Related]  

  • 5. A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome.
    Rustin MH; Grimes SM; Kovacs IB; Cooke ED; Bowcock SA; Sowemimo-Coker SO; Turner P; Kirby JD
    Eur J Clin Pharmacol; 1984; 27(1):61-5. PubMed ID: 6386490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
    Baadsgaard O; Schmidt JF; Ironmann L
    Ugeskr Laeger; 1983 Dec; 145(49):3814-6. PubMed ID: 6364517
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymoxamine for Raynaud's disease and chilblains.
    Jaffe GV; Grimshaw JJ
    Br J Clin Pract; 1980; 34(11-12):343-6. PubMed ID: 6450602
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of raynaud's disease and phenomenon with intraarterial reserpine (author's transl)].
    González Folch M; Saffie F
    Rev Med Chil; 1976 Jan; 104(1):21-4. PubMed ID: 788084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
    Dumoulin J
    Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383
    [No Abstract]   [Full Text] [Related]  

  • 10. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.
    Allegra C; Tonelli V; Bonifacio M; Mari A; Assogna G
    Boll Chim Farm; 1985 Oct; 124(10):121S-124S. PubMed ID: 2935173
    [No Abstract]   [Full Text] [Related]  

  • 11. [Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study].
    Madsen JL; Hvidt S
    Ugeskr Laeger; 1984 Sep; 146(36):2695-7. PubMed ID: 6393495
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.
    Holti G
    Practitioner; 1982 Apr; 226(1366):781-3. PubMed ID: 7045853
    [No Abstract]   [Full Text] [Related]  

  • 13. Raynaud's phenomenon.
    O'connor CM
    J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A double-blind clinical trial of a topical preparation with a base of biochemical precursors of glucosaminoglycan (GAG) in patients suffering from Raynaud's disease].
    Signorini GP
    Boll Chim Farm; 1986 Oct; 125(10):103S-110S. PubMed ID: 3551995
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of Raynaud's phenomenon in a healthy Spanish population.
    Riera G; Vilardell M; Vaqué J; Fonollosa V; Bermejo B
    J Rheumatol; 1993 Jan; 20(1):66-9. PubMed ID: 8441168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raynaud's disease and syndromes].
    Montorsi W
    Minerva Med; 1974 Nov; 65(78):4087-111. PubMed ID: 4431575
    [No Abstract]   [Full Text] [Related]  

  • 17. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease].
    Acevedo A; Palacios JM; López R; Palma F
    Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168
    [No Abstract]   [Full Text] [Related]  

  • 19. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
    Pisenti L; Hart LL
    Drug Intell Clin Pharm; 1984 Mar; 18(3):213-4. PubMed ID: 6365494
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.